Skip to content

An Explorative Randomized Controlled Investigation Evaluating Newly Developed Ostomy Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02351817
Enrollment
10
Registered
2015-01-30
Start date
2015-02-28
Completion date
2015-03-31
Last updated
2016-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy

Brief summary

The primary objective of the investigation is to explore the acceptance of a newly developed adhesive.

Interventions

DEVICETest A

Ostomy appliance

DEVICETest B

Ostomy appliance

DEVICEBaseline

Ostomy appliance

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have given written informed consent and letter of authority * Be at least 18 years of age and have full legal capacity * Be able to handle the products her/himself * Have an ileostomy with a diameter between 10 and 30 mm * Willing to follow the product change schedule (one change per day) * Have had their ostomy for at least three months * Willing to use 1 piece open ostomy products during the test period * Must be able to use a custom cut product * Have intact skin * Negative result of a pregnancy test for women of childbearing age

Exclusion criteria

* Currently receiving or have within the past 2 months received radio- and/or chemotherapy * Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/ injection) treatment * Is pregnant or breastfeeding. * Is participating in other interventional clinical investigations or have previously participated in this investigation * Have a loop ileostomy * Known hypersensitivity towards any of the test products

Design outcomes

Primary

MeasureTime frameDescription
Product Acceptance7 days per test periodProduct acceptance was measurement qualitatively by interviews exploring the factors and mechanisms affecting the acceptance. The interview questions were formulated in such a way that was not possible to quantify the number of subjects accepting the test products. There were problems with test product performance and handling and therefore the acceptance of the products was not high. Product preference was secondary endpoint, where the subjects were asked whether they preffered their own product over the test products. This endpoint is the best measure we have for mimiking product acceptance. However, we are aware subjects could accept a product without preferring it over own product and the preferrence result might therefore not be accurate. The result presented below shows how many subjects preferred Test A/Test B over own product

Countries

Denmark

Participant flow

Participants by arm

ArmCount
Overall Study Population
The investigation is a cross-over investigation therefore baseline data is presented for the overall population
10
Total10

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1Adverse Event12
Period 1Lack of Efficacy01
Period 2Adverse Event02
Period 2Protocol Violation10

Baseline characteristics

CharacteristicOverall Study Population
Age, Continuous57.0 years
STANDARD_DEVIATION 9.5
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
1 / 103 / 102 / 10
serious
Total, serious adverse events
0 / 100 / 100 / 10

Outcome results

Primary

Product Acceptance

Product acceptance was measurement qualitatively by interviews exploring the factors and mechanisms affecting the acceptance. The interview questions were formulated in such a way that was not possible to quantify the number of subjects accepting the test products. There were problems with test product performance and handling and therefore the acceptance of the products was not high. Product preference was secondary endpoint, where the subjects were asked whether they preffered their own product over the test products. This endpoint is the best measure we have for mimiking product acceptance. However, we are aware subjects could accept a product without preferring it over own product and the preferrence result might therefore not be accurate. The result presented below shows how many subjects preferred Test A/Test B over own product

Time frame: 7 days per test period

Population: One subject did not answer the preference question.

ArmMeasureValue (NUMBER)
Test AProduct Acceptance0 participants
Test BProduct Acceptance1 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026